loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Tesetaxel

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Tesetaxel

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Odonate Announces Planned Return of Capital to Stockholders
    Odonate Announces Planned Return of Capital to Stockholders

    17 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211117005445/en

    BUSINESSWIRE
    17 Nov 2021
    Share Share
    Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients
    Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients

    11 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201211005106/en

    BUSINESSWIRE
    11 Dec 2020
    Share Share
    Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients
    Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients

    11 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201211005106/en/Positive-Results-of-CONTESSA-a-Phase-3-Study-of-Tesetaxel-in-Patients-with-Metastatic-Breast-Cancer-Presented-at-the-2020-San-Antonio-Breast-Cancer-Symposium-SABCS

    BUSINESSWIRE
    11 Dec 2020
    Share Share